Antisense Strategies in Therapy of Gliomas

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|6|3|411-423

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.3, 2011-09, pp. : 411-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 53-69

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 2-12

Bentham Science Publishers

Access to resources Recommend Favorite

Proton therapy for low‐grade gliomas: Results from a prospective trial

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1712-1719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 217-235

Bentham Science Publishers

Access to resources Recommend Favorite

Exosome-based strategies for Diagnosis and Therapy

By  

Recent Patents on CNS Drug Discovery, Vol. 10, Iss. 1, 2015-01 ,pp. : 10-27

Bentham Science Publishers

Access to resources Recommend Favorite